By 2060, new dementia cases per year could double to one million because of the growing population of older Americans, a ...
New research suggests that the risk for developing dementia is significantly higher than previously estimated, and the burden ...
Dementia, a progressive disorder that impacts memory and independence, affects millions globally. While many are aware of ...
The evidence of gabapentin and dementia is mixed, with two studies looking at hundreds of thousands of people and coming to ...
Appropriate use criteria (AUC) for the use of amyloid and tau positron emission tomography (PET) have been issued by the ...
In a mouse study, researchers found that zolpidem (Ambien), a common sleep aid, could prevent the brain from effectively ...
A doctor who punched a dementia patient in the head and pushed his head into a pillow, has been erased from the medical ...
Leqembi's subcutaneous dosing allows Alzheimer's patients to administer weekly treatment at home in 15 seconds ... s disease ...
The FDA has accepted the BLA for lecanemab-irmb SC for weekly maintenance dosing in the treatment of early Alzheimer disease.
BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announced that the U.S. Food and Drug Administration (FDA) has accepted BioArctic's partner Eisai's Biologics License Application (BLA) for Leqembi ...
The risk of developing dementia may be much higher than previously thought, a study published Monday in the journal Nature ...